Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absorb, capsule, channel, cohesive, De, domestic, entitled, entity, factor, illustrate, Lage, Landen, negotiate, nonfinancial, predecessor, principle, promised, salary, secondary, temporarily, trademarked, unanticipated, unexercised, unused, waived
Removed:
accreted, adjustment, affiliate, allocated, anniversary, bearing, bore, borrowed, converted, defaulted, deliver, designated, discount, doubt, exclusive, extended, fee, finite, forbearance, forgo, formula, holder, Immune, Imperium, indirectly, Master, matured, Pomegranate, preceding, premium, projected, reclassification, Redeemable, repayment, resale, Reservatol, Reservatrol, restructuring, split, Supplemental, transaction, undiscounted, wholly
Filing tables
Filing exhibits
INBP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-37509, 333-87456 and 333-87458) and the Registration Statements on Form S-3 (Nos. 333-121601, 333-144155 and 333-149855) of Integrated BioPharma, Inc., of our report, dated September 8, 2014 relating to the consolidated financial statements as of June 30, 2014 and June 30, 2013 and the fiscal years then ended, which is included in this Form 10-K.
/s/ Friedman LLP
East Hanover, New Jersey
September 8, 2014